Why do patients return to work more quickly after an epidural steroid injection (ESI) compared to surgery, and is an epidural steroid injection required before surgery?

Why Patients Return to Work Quicker with ESI vs Surgery

Patients return to work more quickly after epidural steroid injections (ESI) compared to surgery because ESI is a minimally invasive outpatient procedure with immediate recovery, while surgery requires operative time, anesthesia, wound healing, and a structured rehabilitation period that delays return to work by weeks to months.

The Fundamental Difference in Recovery Trajectories

The return-to-work disparity stems from the nature of the interventions themselves:

• ESI involves: A needle-based injection performed in an outpatient setting, typically completed in 15-30 minutes, with patients walking out the same day and often returning to work within 1-3 days
• Surgery involves: General or spinal anesthesia, tissue dissection, bone work (often laminectomy or discectomy), wound closure, immediate postoperative restrictions, and a graduated return to activity over 6-12 weeks

The physical trauma and healing requirements are fundamentally different. Surgery creates tissue damage that must heal before full activity resumption, while ESI causes only needle-tract trauma.

Is ESI Required Before Surgery?

No, ESI is not universally required before surgery, but it is strongly recommended as a conservative treatment trial in most clinical pathways 1, 2.

The Clinical Rationale for Attempting ESI First:

• 77% of surgical candidates avoided surgery after ESI in one study, with symptom resolution lasting 12-27 months 3
• ESI provides meaningful short-term relief (1-5 months) in most patients, with some experiencing benefits up to one year 4, 5
• Surgery has higher immediate risks: infection, dural tear, neurological injury, and the inherent risks of anesthesia
• ESI allows time for natural disc resorption: herniated disc material often resorbs spontaneously over 3-6 months, potentially eliminating the need for surgery

When ESI Can Be Bypassed:

Surgery may be pursued without ESI trial in:

• Cauda equina syndrome (surgical emergency)
• Progressive motor weakness (urgent surgical indication)
• Severe, intractable pain unresponsive to oral medications where waiting is not tolerable
• Patient preference after informed discussion of risks/benefits

Evidence on ESI Effectiveness and Surgical Outcomes

The 2025 BMJ guideline 1 provides strong recommendations against ESI for chronic axial (non-radicular) low back pain, but the evidence for radicular pain from disc herniation is more nuanced. The guideline notes that patients value small but important pain relief and would accept typical procedural risks for improvement approximating 1.5 cm on a 10 cm visual analogue scale.

Critical finding: Patients who receive preoperative ESI do not have increased surgical complication rates (infection, dural tear, neurological complications) even when ESI is given in close proximity to surgery 6. However, they do experience higher rates of reoperations and readmissions, likely reflecting a more complex patient population with chronic pain patterns 6.

The Work Status Factor

One older study 7 found that 52% of patients with work-related injury responded to ESI versus 68% with non-work-related injury, though this difference was not statistically significant. This suggests that secondary gain and psychosocial factors may influence outcomes more than the injection itself in some populations.

Practical Algorithm for Clinical Decision-Making

For patients with lumbar radiculopathy from disc herniation:

1. First-line: Trial of oral medications (NSAIDs, neuropathic pain agents) + physical therapy for 4-6 weeks
2. Second-line: ESI if symptoms persist and no red flags present
   • Use fluoroscopy or ultrasound guidance for accuracy 1, 8
   • Transforaminal approach superior to interlaminar for single-level pathology 9, 8
   • Betamethasone provides longest duration of relief; avoid dexamethasone 8
   • Expect peak benefit at 1-5 months post-injection 5
3. Surgical referral if:
   • No meaningful improvement after 1-2 ESI attempts (spaced 2-4 weeks apart)
   • Symptoms recur within 3 months of ESI
   • Progressive neurological deficit develops
   • Patient preference after failed conservative care

Important Caveats

• ESI is not a cure: It provides temporary symptom relief while natural healing occurs or to avoid surgery in patients who are poor surgical candidates
• Severe stenosis responds poorly: Patients with severe stenosis have significantly weaker pain relief from ESI 8
• Catastrophic risks exist: Though rare, paralysis and death have been reported with ESI 1
• Surgery provides more durable long-term results: When conservative care fails, surgery offers more immediate and sustained improvement 4

The faster return to work with ESI is simply a reflection of the minimal invasiveness of the procedure, not necessarily superior long-term outcomes compared to surgery in appropriate candidates.